InvestorsObserver
×
News Home

Should You Sell Ardelyx Inc (ARDX) in Biotechnology Industry?

Monday, March 20, 2023 10:57 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Sell Ardelyx Inc (ARDX) in Biotechnology Industry?

A rating of 97 puts Ardelyx Inc (ARDX) near the top of the Biotechnology industry according to InvestorsObserver. Ardelyx Inc's score of 97 means it scores higher than 97% of stocks in the industry. Ardelyx Inc also received an overall rating of 84, putting it above 84% of all stocks. Biotechnology is ranked 38 out of the 148 industries.

Overall Score - 84
ARDX has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on ARDX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 84 would rank higher than 84 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Ardelyx Inc Stock Today?

Ardelyx Inc (ARDX) stock is lower by -4.07% while the S&P 500 has risen 0.61% as of 10:54 AM on Monday, Mar 20. ARDX has fallen -$0.17 from the previous closing price of $4.05 on volume of 3,003,934 shares. Over the past year the S&P 500 has fallen -11.67% while ARDX has risen 266.98%. ARDX lost -$0.42 per share the over the last 12 months. Click Here to get the full Stock Report for Ardelyx Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App